| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 552 | 2024 |
| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 528 | 2023 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 517 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 514 | 2024 |
| Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 M Naghavi, SE Vollset, KS Ikuta, LR Swetschinski, AP Gray, EE Wool, ... The Lancet 404 (10459), 1199-1226, 2024 | 379 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 319 | 2024 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 225 | 2024 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, ... The Lancet Neurology 23 (10), 973-1003, 2024 | 100 | 2024 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The lancet 403 (10440), 2057-2099, 2024 | 95 | 2024 |
| Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021 SB Sirota, MC Doxey, RMV Dominguez, RG Bender, A Vongpradith, ... The Lancet Infectious Diseases 25 (1), 36-51, 2025 | 10 | 2025 |
| Global, regional, and national burden of pulmonary arterial hypertension, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 PJ Leary, M Lindstrom, CO Johnson, S Emmons-Bell, S Rich, PA Corris, ... The Lancet Respiratory Medicine 13 (1), 69-79, 2025 | 9 | 2025 |
| Assessing mental health among students in the UAE: A cross-sectional study utilizing the DASS-21 scale SO Alalalmeh, OE Hegazi, M Shahwan, N Hassan, GRH Alnuaimi, ... Saudi Pharmaceutical Journal 32 (4), 101987, 2024 | 9 | 2024 |
| NAFLD and nutraceuticals: a review of completed phase III and IV clinical trials OE Hegazi, SO Alalalmeh, GRH Alnuaimi, M Shahwan, AA Jairoun, ... Frontiers in Medicine 10, 1227046, 2023 | 7 | 2023 |
| Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021 A Carter, M Zhang, KH Tram, MK Walters, D Jahagirdar, ED Brewer, ... The Lancet HIV 11 (12), e807-e822, 2024 | 5 | 2024 |
| Exploring Promising Therapies for Non-Alcoholic Fatty Liver Disease: A ClinicalTrials. gov Analysis OE Hegazi, SO Alalalmeh, M Shahwan, AA Jairoun, MM Alourfi, ... Diabetes, Metabolic Syndrome and Obesity, 545-561, 2024 | 4 | 2024 |
| An examination of global research trends for exploring the associations between the gut microbiota and nonalcoholic fatty liver disease through bibliometric and visualization … SH Zyoud, SO Alalalmeh, OE Hegazi, M Shakhshir, F Abushamma, ... Gut Pathogens 16 (1), 31, 2024 | 3 | 2024 |
| Amphetamines in child medicine: a review of ClinicalTrials. gov SO Alalalmeh, OE Hegazi, M Shahwan, FS Alshehri, AM Ashour, ... Frontiers in Pharmacology 14, 1280562, 2023 | 3 | 2023 |
| Relation of erythrocyte sedimentation rate, glycemic parameters and lipid profile for the prediction of major adverse cardiovascular events: a single-center, cross-sectional … M Shahwan, AA Jairoun, RFF Alaila, GRH Alnuaimi, SO Alalalmeh, ... Obesity Medicine 43, 100513, 2023 | 3 | 2023 |
| Development, validation, and utilization of a social media use and mental health questionnaire among middle eastern and western adults: A pilot study from the UAE O Hegazi, S Alalalmeh, A Alfaresi, S Dashtinezhad, A Bahada, ... International Journal of Environmental Research and Public Health 19 (23), 16063, 2022 | 2 | 2022 |
| Mapping the global research landscape on nonalcoholic fatty liver disease and insulin resistance: A visualization and bibliometric study HZ Sa'ed, OE Hegazi, SO Alalalmeh, M Shakhshir, F Abushamma, ... World Journal of Hepatology 16 (6), 951, 2024 | | 2024 |
Omar E. HegaziResearcherEmail yang diverifikasi di ajmanuni.ac.ae